Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Current Assets: 2021-2025

Historic Current Assets for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $231.4 million.

  • Prime Medicine's Current Assets fell 5.96% to $231.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.4 million, marking a year-over-year decrease of 5.96%. This contributed to the annual value of $211.9 million for FY2024, which is 48.20% up from last year.
  • Prime Medicine's Current Assets amounted to $231.4 million in Q3 2025, which was up 90.79% from $121.3 million recorded in Q2 2025.
  • Prime Medicine's Current Assets' 5-year high stood at $296.6 million during Q4 2022, with a 5-year trough of $121.3 million in Q2 2025.
  • In the last 3 years, Prime Medicine's Current Assets had a median value of $211.9 million in 2024 and averaged $196.6 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 51.80% in 2023, then skyrocketed by 48.20% in 2024.
  • Quarterly analysis of 5 years shows Prime Medicine's Current Assets stood at $270.6 million in 2021, then grew by 9.62% to $296.6 million in 2022, then slumped by 51.80% to $143.0 million in 2023, then skyrocketed by 48.20% to $211.9 million in 2024, then declined by 5.96% to $231.4 million in 2025.
  • Its Current Assets stands at $231.4 million for Q3 2025, versus $121.3 million for Q2 2025 and $163.8 million for Q1 2025.